<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
	"http://www.w3.org/TR/1998/REC-html40-19980424/loose.dtd">
<html>
<head><meta http-equiv="content-type" content="text/html; charset=UTF-8">
<style type="text/css">
 table.main {}
 tr.row {}
 td.cell {}
 div.block {}
 div.paragraph {}
 .font0 { font:6pt Arial, sans-serif; }
 .font1 { font:7pt Arial, sans-serif; }
 .font2 { font:8pt Arial, sans-serif; }
 .font3 { font:14pt Arial, sans-serif; }
 .font4 { font:10pt Times New Roman, serif; }

</style>
</head>
<body>
<p><span class="font3">J.P. Morgan</span></p>
<p><span class="font2" style="font-weight:bold;">Asia Pacific Equity Research</span></p>
<p><span class="font1" style="font-weight:bold;">07 September 2016</span></p>
<p><span class="font1" style="font-weight:bold;">Isabella Y. Zhao, CFA</span></p>
<p><span class="font1" style="font-weight:bold;">(852) 2800-8534</span></p>
<p><a href="mailto:isabella.zhao@jpmorgan.com"><span class="font1" style="font-weight:bold;">isabella.zhao@jpmorgan.com</span></a></p>
<p><span class="font4" style="font-weight:bold;">Analyst Certification: </span><span class="font4">The research analyses) denoted by an “AC” on the cover of this report certifies (or, where multiple research analysts are primarily responsible for this report, the research analyst denoted by an “AC” on the cover or within the document individually certifies, with respect to each security or issuer that the research analyst covers in this research) that: (1) all of the views expressed in this report accurately reflect his or her personal views about any and all of the subject securities or issuers; and (2) no part of any of the research analyst's compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed by the research analyst(s) in this report. For all Korea-based research analysts listed on the front cover, they also certify, as per KOFI A requirements, that their analysis was made in good faith and that the views reflect their own opinion, without undue influence or intervention.</span></p>
<p><span class="font4" style="font-weight:bold;">Important Disclosures</span></p>
<ul style="list-style:none;"><li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Market Maker/ Liquidity Provider: </span><span class="font4">J.P. Morgan Securities plc and/or an affiliate is a market maker and/or liquidity provider in securities issued by Fosun Pharmaceutical - H.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Client: </span><span class="font4">J.P. Morgan currently has, or had within the past 12 months, the following entity(ies) as clients: Fosun Pharmaceutical - H.</span></p></li>
<li>
<p><span class="font4" style="font-weight:bold;">• &nbsp;&nbsp;&nbsp;Other Significant Financial Interests: </span><span class="font4">J.P. Morgan owns a position of 1 million USD or more in the debt securities of Fosun Pharmaceutical - H.</span></p></li>
<li>
<p><span class="font4">• &nbsp;&nbsp;&nbsp;MSCI: The MSCI sourced information is the exclusive property of MSCI. Without prior written permission of MSCI, this information and any other MSCI intellectual properly may not be reproduced, redisseminated or used to create any financial products, including any indices. This information is provided on an 'as is' basis. The user assumes the entire risk of any use made of this information. MSCI, its affiliates and any third party involved in, or related to, computing or compiling the information hereby expressly disclaim all warranties of originality, accuracy, completeness, merchantability or fitness for a particular purpose with respect to any of this information. Without limiting any of the foregoing, in no event shall MSCI, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. MSCI and the MSCI indexes are services marks of MSCI and its affiliates.</span></p></li></ul>
<p><span class="font4" style="font-weight:bold;">Company-Specific Disclosures: </span><span class="font4">Important disclosures, including price charts and credit opinion history tables, are available for compendium reports and all J.P. Morgan-covered companies by visiting </span><a href="https://jpmm.com/research/disclosures"><span class="font4" style="text-decoration:underline;">https://jpmm.com/research/disclosures</span></a><span class="font4" style="text-decoration:underline;">,</span><span class="font4"> calling 1-800-477-0406, or e-mailing </span><a href="mailto:research.disclosure.inquiries@jpmorgan.com"><span class="font4" style="text-decoration:underline;">research.disclosure.inquiries@jpmorgan.com</span></a><span class="font4"> with your request. J.P. Morgan’s Strategy, Technical, and Quantitative Research teams may screen companies not covered by J.P. Morgan. For important disclosures for these companies, please call 1-800-477-0406 or e-mail </span><a href="mailto:research.disclosure.inquiries@ipmorgan.com"><span class="font4" style="text-decoration:underline;">research.disclosure.inquiries@ipmorgan.com</span></a><span class="font4">.</span></p>
<div>
</div><br clear="all">
<div>
<table border="1">
<tr><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Date</span></p></td><td style="vertical-align:middle;">
<p><span class="font2" style="font-weight:bold;">Rating</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">Share Price (HK$)</span></p></td><td style="vertical-align:bottom;">
<p><span class="font2" style="font-weight:bold;">Price Target (HK$)</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">03-Dec-12</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">OW</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">11.20</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">17.00</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">31-Oct-13</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">OW</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">17.98</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">22.50</span></p></td></tr>
<tr><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">27-Mar-14</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">OW</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">26.70</span></p></td><td style="vertical-align:bottom;">
<p><span class="font1" style="font-weight:bold;">33.00</span></p></td></tr>
<tr><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">10-Nov-14</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">OW</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">26.15</span></p></td><td style="vertical-align:top;">
<p><span class="font1" style="font-weight:bold;">35.80</span></p></td></tr>
<tr><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">14-Aug-15</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">NR</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">22.60</span></p></td><td style="vertical-align:middle;">
<p><span class="font1" style="font-weight:bold;">-</span></p></td></tr>
</table>
</div><br clear="all">
<p><span class="font4">The chart(s) show J.P. Morgan's continuing coverage of the stocks; the current analysts may or may not have covered it over the entire period.</span></p>
<p><span class="font4">J.P. Morgan ratings or designations: OW = Overweight, N= Neutral, UW = Underweight, NR = Not Rated</span></p>
<p><span class="font1" style="font-weight:bold;">33</span></p>
</body>
</html>